Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Circadian rhythm-related genes refer collectively to a group of core transcription factors and regulatory proteins that govern the intrinsic biological 24-hour rhythm in nearly all mammalian cells. The canonical genes include Period (PER1, PER2, PER3), Cryptochrome (CRY1, CRY2), CLOCK, and BMAL1, which interact through transcription-translation feedback loops (TTFLs) to maintain rhythmic oscillations in gene and protein expression. These oscillations underlie diverse biological functions—ranging from sleep-wake cycles to hormone secretion, metabolism, cell division, and behavior. Dysregulation or mutation of these genes is implicated in multiple disorders, including cancer, sleep disruption, neurodegeneration, mood disorders, and cardiometabolic syndrome[2][4][5][7]. However, “circadian rhythm-related genes” is a descriptive collective term, not a single molecular target—making it an improper entry for canonical molecular target databases. Individual members (e.g., Period circadian regulator 2 (PER2)) are recognized as discrete, structurally defined targets. Key points and clarification: - The term "circadian rhythm-related genes" encompasses multiple distinct transcription factors and not a unique molecular entity[1][2][5]. - Each gene/family (e.g., PER1, PER2, CRY1, BMAL1) has its own nomenclature, structure, and regulatory roles[1][2][4][5]. - As a group name, it is not a specific drug target or molecular classification, but several members are of high biomedical interest as disease biomarkers or drug targets[1]. - For structured databases, canonical target entries should use specific gene/protein designations (e.g., "Period circadian regulator 2 (PER2)") instead of group labels. If you require structured target entries, please provide or select one specific gene or protein from the circadian system (such as PER2, CRY1, BMAL1, CLOCK).
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Circadian rhythm-related gene (null).